Literature DB >> 17705765

Comparison of intraoperative parameters and perioperative complications of retroperitoneal and transperitoneal approaches to laparoscopic partial nephrectomy: support for a retroperitoneal approach in selected patients.

Kathleen Kieran1, Jeffrey S Montgomery, Stephanie Daignault, William W Roberts, J Stuart Wolf.   

Abstract

BACKGROUND AND
PURPOSE: Retroperitoneal laparoscopy (RP) may have some intrinsic advantages over transperitoneal laparoscopy (TP) in certain patients undergoing partial nephrectomy. We reviewed our experience with RP and TP partial nephrectomy to identify differences in intraoperative and postoperative parameters. PATIENTS AND METHODS: The records of 72 patients (45 TP, 27 RP) undergoing laparoscopic partial nephrectomy without hand assistance between January 2003 and August 2005 were reviewed. The two groups were similar demographically; tumors were smaller in RP patients (2.1 v 2.7 cm; P = 0.03), and the RP approach was used more frequently on right kidneys (70.4% v 37.8%; P = 0.01).
RESULTS: The operative time (mean 160 v 192 minutes; P = 0.008) and length of stay (LOS; median 1.0 days [range 1-10 days] v 2.0 days [range 1-64 days]; P = 0.001) were shorter in RP patients. Rates of collecting system entry (22% v 38%), positive-margin rate (0% v 6.7%; P = 0.29), and complications (19% v 22%; P = 0.77) were similar in RP and TP patients. Hemorrhage was the most common complication in both groups. Bowel-related complications occurred in three TP patients, but in no RP patients. Overall, the median estimated blood loss (EBL) was lower in RP patients (100 mL [range 25-3500 mL] v 225 mL [range 25-1900 mL]; P = 0.06). Among patients with complications, EBL was similar in both groups (median 325 mL [50-1500 mL] v 200 mL [50-3500 mL] for RP and TP; P = 0.86).
CONCLUSIONS: The RP approach reduces operative time, LOS, and some types of complications without compromising the quality of tumor resection. Complications in the retroperitoneal space are not associated with higher EBL. Anatomic considerations and surgeon experience may improve outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17705765     DOI: 10.1089/end.2007.0337

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

Review 1.  Robotic retroperitoneal partial nephrectomy.

Authors:  Mayank Patel; James Porter
Journal:  World J Urol       Date:  2013-02-13       Impact factor: 4.226

2.  Transperitoneal versus retroperitoneal robotic partial nephrectomy: matched-pair comparisons by nephrometry scores.

Authors:  Seol Ho Choo; Seo Yeon Lee; Hyun Hwan Sung; Hwang Gyun Jeon; Byong Chang Jeong; Seong Soo Jeon; Hyun Moo Lee; Han Yong Choi; Seong Il Seo
Journal:  World J Urol       Date:  2014-05-10       Impact factor: 4.226

3.  Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma.

Authors:  Feiya Yang; Qiang Zhou; Nianzeng Xing
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-01       Impact factor: 4.553

4.  Laparoscopic partial nephrectomy: Technical considerations and an update.

Authors:  Jose L Dominguez-Escrig; Nikhil Vasdev; Anna O'Riordon; Naeem Soomro
Journal:  J Minim Access Surg       Date:  2011-10       Impact factor: 1.407

5.  Classification of positive surgical margins and tumor recurrence after nephron-sparing surgery for small renal masses.

Authors:  Gang Li; Dong-Sheng Zhu; Zhi-Qiang Lang; Ai-Xiang Wang; Yu-Hong Li; Ren-Ya Zhang; Yuan-Jie Niu
Journal:  Cancer Manag Res       Date:  2018-12-03       Impact factor: 3.989

6.  Transperitoneal approach versus retroperitoneal approach: a meta-analysis of laparoscopic partial nephrectomy for renal cell carcinoma.

Authors:  Tong Ren; Yan Liu; Xiaowen Zhao; Shaobin Ni; Cheng Zhang; Changgang Guo; Minghua Ren
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

7.  Laparoscopic Nephrectomy in Patients with Previous Abdominal Surgery.

Authors:  Mohamed O Breish; Danielle Whiting; Seshadri Sriprasad
Journal:  Cureus       Date:  2020-02-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.